Incozen Therapeutics Private Limited

Drug discovery and development services for early-stage drug candidates, recognized by Department of Scientific and Industrial Research.

2008 | Hyderabad, Telangana (India) | Active
Last Updated: December 24, 2024

Incozen Therapeutics Profile

Key Indicators

  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 2.00 Cr
  • Company Age 16 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 2.49 Cr
  • Revenue Growth 3.96%
  • Profit Growth -41.34%
  • Ebitda -12.66%
  • Net Worth 10.67%
  • Total Assets 52.08%

About Incozen Therapeutics

Incozen Therapeutics Private Limited (ITPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 July 2008 and has a history of 16 years and seven months. Its registered office is in Hyderabad, Telangana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.

The company has closed loans amounting to ₹2.49 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

Pranav Amin, Shaunak Amin, Satya Vakkalanka, and One other member serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    incozen.com

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24239TG2008PTC059967

  • Company No.

    059967

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    03 Jul 2008

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

What products or services does Incozen Therapeutics Private Limited offer?

Incozen Therapeutics Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services.

Who are the key members and board of directors at Incozen Therapeutics?

Board Members (4)

NameDesignationAppointment DateStatus
Pranav Amin Country flag representing In Director 25-Nov-2008Current
Shaunak Amin Country flag representing In Director 25-Nov-2008Current
Satya Vakkalanka Country flag representing In Director 30-Aug-2008Current
Thappali Manikandan Country flag representing In Director 26-Aug-2022Current

Financial Performance of Incozen Therapeutics.

Incozen Therapeutics Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.96% increase. The company also saw a substantial fall in profitability, with a 41.34% decrease in profit. The company's net worth Soared by an impressive increase of 10.67%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
3.96%
Revenue from Operations
3.46%
Total Assets
52.08%
Profit or Loss
-41.34%
Net Worth
10.67%
EBITDA
-12.66%

What is the Ownership and Shareholding Structure of Incozen Therapeutics?

In 2022, Incozen Therapeutics had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹2.49 Cr

Charges Breakdown by Lending Institutions

  • Others : 2.49 Cr

Latest Charge Details

DateLenderAmountStatus
29 Aug 2011Others₹2.49 CrSatisfied

How Many Employees Work at Incozen Therapeutics?

Incozen Therapeutics has a workforce of 26 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Incozen Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Incozen Therapeutics's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Incozen Therapeutics

Recent activity within the organization

  • Annual General Meeting

    Incozen Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Incozen Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

    31 Mar 2024

  • Director Appointment

    Thappali Ramaswamy Sethuraman Satheesh Manikandan was appointed as a Director was appointed as a Director on 26 Aug 2022 & has been associated with this company since 2 years 5 months .

    26 Aug 2022

  • Charges

    A charge registered on 29 Aug 2011 via Charge ID 10309538 with Others was fully satisfied on 07 Feb 2020.

    07 Feb 2020

  • Charges

    A charge with Others of Rs. 2.49 Cr registered on 29 Aug 2011 with Charge ID 10309538 was modified on 03 Jan 2017.

    03 Jan 2017

  • Charges

    A charge with Others amounted to Rs. 2.49 Cr with Charge ID 10309538 was registered on 29 Aug 2011.

    29 Aug 2011

Frequently asked questions

  • Incozen Therapeutics Private Limited was incorporated on 03 Jul 2008.

  • The authorized share capital of Incozen Therapeutics Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 2.00 Cr.

  • Currently 4 directors are associated with Incozen Therapeutics Private Limited.

    • Pranav Chirayu Amin
    • Shaunak Chirayu Amin
    • Satya Kameswari Vakkalanka
    • Thappali Ramaswamy Sethuraman Satheesh Manikandan
  • As per Ministry of Corporate Affairs (Mca), the registered address of Incozen Therapeutics Private Limited is Office No. 01B2 12A01B2 12A(13Th) Floor Manjeera Trinity Corporation Jntu Rd, K Ukatpally India, Hyderabad, Telangana, 500072.

  • The corporate identification number (CIN) of Incozen Therapeutics Private Limited is U24239TG2008PTC059967 and the company number is 059967 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Incozen Therapeutics Private Limited is https://www.incozen.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Incozen Therapeutics Private Limited has risen by 3.96%.

  • As Per 2022 financial reports, 26 employees are currently employed by Incozen Therapeutics Private Limited.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Incozen Therapeutics Private Limited has experienced an upsurge of 10.67%.

  • The most recent Balance Sheet for Incozen Therapeutics Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Pharma Contract R&D